Afrikaans
Akan
Albanian
Amharic
Arabic
Armenian
Azerbaijani
Basque
Belarusian
Bemba
Bengali
Bihari
Bosnian
Breton
Bulgarian
Cambodian
Catalan
Cebuano
Cherokee
Chichewa
Chinese (Simplified)
Chinese (Traditional)
Corsican
Croatian
Czech
Danish
Dutch
English
Esperanto
Estonian
Ewe
Faroese
Filipino
Finnish
French
Frisian
Ga
Galician
Georgian
German
Guarani
Gujarati
Haitian Creole
Hausa
Hawaiian
Hebrew
Hindi
Hmong
Hungarian
Icelandic
Igbo
Indonesian
Interlingua
Irish
Italian
Japanese
Javanese
Kannada
Kazakh
Kinyarwanda
Kirundi
Kongo
Korean
Krio (Sierra Leone)
Kurdish
Kurdish (Soranî)
Kyrgyz
Laothian
Latin
Latvian
Lingala
Lithuanian
Lozi
Luganda
Luo
Luxembourgish
Macedonian
Malagasy
Malay
Malayalam
Maltese
Maori
Marathi
Mauritian Creole
Moldavian
Mongolian
Myanmar (Burmese)
Montenegrin
Nepali
Nigerian Pidgin
Northern Sotho
Norwegian
Norwegian (Nynorsk)
Occitan
Oriya
Oromo
Pashto
Persian
Polish
Portuguese (Brazil)
Portuguese (Portugal)
Punjabi
Quechua
Romanian
Romansh
Runyakitara
Russian
Samoan
Scots Gaelic
Serbian
Serbo-Croatian
Sesotho
Setswana
Seychellois Creole
Shona
Sindhi
Sinhalese
Slovak
Slovenian
Somali
Spanish
Spanish (Latin American)
Sundanese
Swahili
Swedish
Tajik
Tamil
Tatar
Telugu
Thai
Tigrinya
Tonga
Tshiluba
Tumbuka
Turkish
Turkmen
Twi
Uighur
Ukrainian
Urdu
Uzbek
Vietnamese
Welsh
Wolof
Xhosa
Yiddish
Yoruba
Zulu
Mother Nature’s stealthiest killer
is the pandemic.
A worldwide spread of infectious disease,
it is a natural disaster for which we have some forewarning,
but this only makes it all the more terrifying.
With an ever more mobile world population,
potentially growing to 11 billion people
by the next century,
public health experts agree
that the possibility of a cataclysmic disease
spreading to all parts of the globe
is more likely now than ever before.
So, what makes pandemics different
from normal infectious diseases
is they’re generally new diseases
into human populations.
They emerge from, typically, wild animals,
through humans coming into contact with those animals.
And something critical needs to happen.
Those viruses, typically viruses,
are not well adapted to humans.
They mutate.
And then when that mutation happens,
they have to start spreading within the human population.
The outbreak needs to get to a certain scale,
and then it really takes off.
What happens when the amount of disease in a community
rises above the expected level for the population?
When there are more cases of infections in hospitals,
the regional authorities and also on the national levels
you have emergency plans to, essentially,
come up with ways to cope
with these increased numbers of people
who turn up at the hospitals.
A pandemic is a whole different thing,
and the main difference is that the virus strain
that hits the population in a pandemic year
is radically different from the virus strains
that had been circulating in the previous years.
The consequence of this is that the population
has no prior immunity
acquired through the previous exposure.
And therefore, the infection rates are just much higher,
and, uh, the number of infected people
that turn up in a hospital is much higher as well.
Among the most devastating pandemics in history
was the Black Death,
which killed at least 75 million people
throughout the 14th century.
By 1400,
it had killed more than 34 million European inhabitants,
or up to 50 percent of the entire population
on the continent.
It would be a mistake to believe that the modern world
isn’t susceptible to a similar kind of widespread outbreak.
With the advent of jet travel,
disease can be spread quite easily
and with terrible rapidity throughout the globe.
But it wasn’t always like this.
At the time of the Agricultural Revolution
roughly 10,000 years ago,
man turned from nomadic life as a hunter-gatherer,
and settled into large communities.
This caused the way that viruses interacted
with the human population to change dramatically.
Agricultural revolution essentially meant
that it became easier to produce food.
And when you can produce more food,
you can have more people living in the same space.
That means the population density goes up, and, um,
this is wonderful for infectious pathogens.
For a virus, it is extremely important
to have a sufficient number of potential victims around.
In a way, the Agricultural Revolution
made it much easier for infections
to go round and round and round and round
in populations in a way that wasn’t possible before.
So it was only when human societies
started having large groups of people,
after we could make our own food through agriculture,
and we started to have towns and cities,
that you got enough people together
to really sustain these sort of epidemic diseases
of the type we’re talking about.
One of the diseases
which has most frequently caused pandemics
to sweep the globe is influenza.
This is because the virus that causes the disease
regularly mutates into a form
for which the general population
has no natural immunity.
Historically,
a new mutated strain of the influenza virus
has appeared three or four times a century,
or roughly every 30 to 40 years.
In the last hundred years,
there have been four deadly flu pandemics.
The Spanish Flu pandemic,
occurring between 1918 and 1919,
may have killed at least 50 million people worldwide.
Astonishingly,
more soldiers died from the 1918 flu
than were killed in the entire war.
Adjusting for population growth,
the number of dead from the Spanish Flu
is equivalent to about 425 million people today.
The most recent influenza pandemic
was the global outbreak known as swine flu,
which occurred between 2009 and 2010.
The viruses that have mutated and caused these pandemics
typically originated from animal influenza viruses.
It is believed that they are bred
as a result of the interaction
between diseases among humans and animals.
In North America and Europe,
seasonal flus occur each autumn and winter.
As the majority of people
will have been exposed to these viruses
in previous seasons,
the symptoms are typically mild.
However, every 20 to 40 years,
the flu virus undergoes a dramatic mutation.
Viruses are parasitic. They’re not alive themselves.
They’re little chunks of genetic material
which modify the cells in our body.
Different viruses target different cells.
So the influenza virus, for instance,
targets certain cells,
basically in the lining of our respiratory system.
And when it enters through our mouth and nose
into our lungs, the virus will attach itself to cells,
enter cells through a complex set of molecular machinery
and then hijack the cellular machinery
to start creating copies of itself.
And those copies will burst out of that cell
into the mucus of our lungs,
and through the process of generating symptoms,
coughing, also gets expelled and move onto the next host.
The flu virus is highly contagious.
each time a sick person coughs,
they expel some 2000 virus-laden droplets.
Sneezing or even talking,
can also generate respiratory droplets.
If you inhale or touch any object
infected with these droplets
and rub your nose or eyes thereafter,
the virus can get through the mucus membranes in your mouth,
nostrils or eyes, and into your airways.
People can be infectious 24 hours
before they even feel ill,
and for five to seven days after they become sick.
Once the flu virus has gotten into your body,
it travels down your airways,
binding to the cells which line the lungs.
When a virus infects us,
there is a whole arsenal of countermeasures
that the organism has provided and is able to provide.
And two very important ones, called T cells
and the other ones, antibodies.
When we vaccinate people that is what we try to induce,
so that you have already T cells and antibodies
that are specific to a virus
that you may encounter later on.
So this is what we want from vaccines.
Most of the symptoms of the flu
are actually caused by what your body does
to try and fight off the virus.
It’s when the body’s cells are under attack
that your immune system kicks in.
Counteroffensive is led
by infection-fighting white blood cells
called T lymphocytes.
T lymphocytes, or T cells,
are often referred to as soldier cells.
In the specific case of the T cells,
one of the important mechanisms to eliminate the virus
is to essentially kill off infected cells.
There are ways to detect that a cell is infected.
And then they go there,
and they have mechanisms to kill off this cell.
This, of course, means there is collateral damage,
because the cell is now not there anymore.
We predominately feel influenza symptoms
in the respiratory system, in the lungs and throat,
because those are the cells the virus targets.
Although the influenza virus only stays in the lungs,
the symptoms of the illness can be felt all over the body.
These include fever, headache,
tiredness and aching muscles,
which is why the flu can make us feel so very ill.
So there are multiple things which cause symptoms
with an infectious disease,
partly it’s affected by the virus itself.
Viruses, as they replicate,
they infect lots of cells and cause damage to the person,
and fever is actually an adaptive response
to help us clear infection because most infections
are tuned to the body’s normal temperature.
By making us hot, the immune system
actually reduces how quickly bacteria and viruses replicate.
The immune system is trying to eliminate the virus,
the infected cells, from the body.
And by doing that, it damages us,
and that can generate inflammation,
can make us feel even sicker,
can, for instance, for flu, cause difficulty in breathing.
According to new estimates published in December of 2017,
between 291,000 and 646,000 people around the world
are killed each year
as a result of catching seasonal influenza.
While seasonal influenza viruses
are detected year-round,
flu viruses peak during the autumn and winter.
It is actually surprisingly unknown
why we have seasonal peaks of influenza.
There are a number of thoughts,
but none of them are completely clear.
One reason appears to be that
the drier and colder conditions make the virus more stable.
Another probably very important factor is that in winter,
we tend to huddle together much more.
And that means, for a virus that has infected one person,
it’s easier to get to the next one.
During an epidemic of seasonal influenza,
most of the terminal cases will be the elderly,
while those with severe complications
usually occur in people with a variety
of pre-existing medical conditions.
By contrast, a flu pandemic can kill younger,
otherwise healthy people,
and cause many more cases of viral pneumonia.
It seems when a completely new virus comes along,
and that’s the situation in a pandemic,
those who have the strongest immune response
may be the ones who suffer most.
And so that’s adolescents, young adults,
and those with the healthiest immune response.
The collateral damage may be what kills you
in that situation.
If you have a really strong immune system,
that gives you a really strong response.
Then your collateral damage may be really massive,
and that’s often what kills you.
In 2009,
the swine flu virus evolved
when a previously combined human-bird-swine virus
underwent a further mutation with a Eurasian pig virus
to form a new H1N1 super virus.
The 2009 swine flu was a classic case
of a very new virus hitting a population
that was immunologically not prepared for it.
So there was no protection
from the viruses that had been around before.
The outbreak first surfaced as an epidemic
in the state of Veracruz, Mexico,
where a 5-year-old boy became ill
with a high fever and typical flu-like symptoms.
It was discovered that he had been infected
with a new kind of variant influenza virus
previously seen only among swine populations.
The boy went down in history as boy zero,
the first person to kick-start the swine flu pandemic.
He was lucky to survive,
though the same cannot be said
for the countless other swine flu victims.
I’m just really scared
because I don’t know, um, if little kids are getting sick
or if there’s a certain medicine for little kids.
In March 2009,
I got a call from my friend and colleague Nancy Cox,
who directs the influenza division
of U.S. Centers for Disease Control in Atlanta,
saying that they had just got
some test results back from California
which indicated that two children who’d been to Mexico
were infected with a previously unknown flu virus.
That became public knowledge,
I think, two or three days later.
We were already gearing up to assist in London,
our colleagues in the United States,
the World Health Organization in London.
And we now know the virus had probably been circulating,
at that point, probably for five or six months,
without really being detected.
But of course, initially,
what people saw were the really quite sick people.
They saw the tip of the iceberg.
People in hospitals in Mexico, and in the United States,
and there was real concern.
We started seeing cases appearing, being detected,
really, across the world in 20, 30 countries within six weeks
of the initial announcement.
And the virus spread very fast.
The first confirmed death from the swine flu virus
occurred at the Texas Children’s Hospital in Houston.
It was a toddler from Mexico City,
who had been visiting family in Brownsville, Texas
before being air-lifted to Houston for treatment.
The World Health Organization’s
Strategic Health Operations Center,
known as the SHOC room, was activated.
For the next few months,
the SHOC room would become the center
of a worldwide battle
against the H1N1 swine flu virus.
On the 24th of April,
the Center for Disease Control
uploaded the complete gene sequences
of the 2009 H1N1 virus to a public influenza database.
Scientists around the world
could now use the sequences
and compare them to samples from their own countries,
in order to more rapidly determine
the spread of the virus.
On Saturday, the 25th of April 2009,
the Director General of the World Health Organization
declared the outbreak a public health emergency
of international concern,
admitting that the swine flu epidemic
could not be successfully contained.
Most cases of severe and fatal infections have been in adults,
in adults between the ages of 30 and 50 years.
This pattern is significantly different
from that seen during epidemics of seasonal influenza.
The pandemic alert level was raised to Phase 4,
indicating that the virus
was spreading abundantly between humans.
On the same day, officials in New York City
reported that they were investigating
a cluster of influenza-like illness in a local high school.
The Center for Disease Control
next confirmed two infections in Kansas,
and another case in Ohio.
In the midst of a bourgeoning public health emergency,
the U.S. began releasing a stockpile of supplies
which could be used to protect and treat the public,
including over 39 million masks and respirators,
gowns, gloves and face shields,
as well as 11 million doses of antiviral drugs.
On the 28th of April,
it was suspected that the virus had further spread to Germany,
with seven more cases being reported from that country.
The following day, the World Health Organization
raised its pandemic alert to Phase 5,
signaling to the global community
that a pandemic was now imminent.
As panic about the virus spread,
draconian measures began to take force around the world.
Egypt began a cull of all domestic pigs in the country.
In Germany’s western state of Saarland,
kissing was banned as a form of personal greeting.
Eventually, more than 70 countries
were reporting cases of infection.
The W.H.O. were forced to raise the threat level to Phase 6,
the highest categorization on the pandemic alert chart.
I have, therefore, decided to raise the level
of influenza pandemic alert from Phase 5
to Phase 6.
The world is now at the start
of the 2009 influenza pandemic.
The world was now facing a global influenza pandemic
for the first time in 41 years.
Throughout June and July,
Europe was experiencing a steep rise in new cases,
with a whopping 11,159 people infected in Britain alone.
Germany followed in second place,
with 2455 confirmed cases.
Throughout the world, immunization was seen
as the only effective means
of stopping the spread of the disease.
However, the new H1N1 vaccine was in short supply.
In America, the CDC recommended
that initial doses be administered to priority groups
such as pregnant women,
people who lived with or cared for babies,
children 6 months to 4 years old,
and health-care workers.
In the U.K., the NHS recommended
that vaccine priority go to people over 6 months old
who were clinically at risk for seasonal flu, pregnant women,
or households of people with compromised immunity.
It was initially proposed that two doses would be required,
but clinical trials demonstrated
that adults were receiving sufficient protection
after only a single injection.
But unfortunately, the vaccine was still
in the process of development,
and would not be ready for use before the end of September.
By that time,
the first official death on German soil was announced.
The country would see further losses of life
throughout October, including the deaths
of a previously healthy 5-year-old boy
and a 48-year-old mother of four.
By November,
a total of 53,968 German nationals
had confirmed infections.
Thirteen people had died as a result.
I think we were lucky in the 2009 pandemic.
The virus wasn’t very pathogenic,
because the rate by which it spread was amazing.
And, um, had it been a virus strain
that gave much more severe flu than the seasonal strains,
then we would have been in deep trouble.
And this was not predictable, that was, if you want,
that was sheer luck.
But despite these tragic figures,
the overall worldwide deaths
from the 2009 to 2010 swine flu outbreak
were fewer than in previous influenza pandemics.
Research shows that as many as 579,000 people
could have perished from the disease,
with figures suggesting
that a disproportionate number of deaths
likely occurred in Southeast Asia and Africa,
where access to prevention and treatment resources
is more limited.
The total number of people infected
was probably about a third of the world’s population
in the first 12 months or so,
but only a minority of those
would have showed any symptoms at all.
Probably only about 10 to 15 percent
of the global population showed symptoms.
Then there were later waves of transmission,
which infected more people
and now, at this point, probably most of them,
90 percent of the world’s population,
have been infected with that virus,
or its descendants.
For the most part,
it seemed that the world had been largely spared
from the major horrors some had predicted.
But it wasn’t long before another highly contagious
and deadly viral disease
threatened to overwhelm the world.
That disease was known as Ebola.
The outbreak of Ebola between 2014 and 2016
was the largest and most complex epidemic of the virus
since it was first discovered in 1976.
It killed a staggering five times more people
than all other known Ebola outbreaks combined.
The outbreak began in Guinea,
before moving across land borders
to Sierra Leone and Liberia,
and eventually found its way to Europe and North America.
There is an incubation period for Ebola
of anywhere from two to 21 days
before the victim will begin displaying
visible symptoms of the disease.
For this reason, the World Health Organization
will only declare the conclusion of an outbreak
once 42 days have elapsed,
the equivalent of two incubation periods
with no new infections being reported.
On average,
roughly half of patients who catch the disease will die.
Historically, there have been outbreaks
where the mortality rate was as high as 90 percent.
It’s a horrible infection to have, frankly.
It causes a widely disseminated infection.
The virus is in almost every body tissue.
Early initial symptoms are mostly gastrointestinal:
profuse diarrhea, vomiting,
with very high-end levels of virus shared.
It can also then cause a hemorrhagic fever,
where you bleed from eyes and other orifices.
It’s got a very high fatality rate.
We think about 60 to 70 percent,
typically, of people die,
usually from multiple organ failure.
It’s one of the most lethal viruses we know.
It spreads from person to person through bodily fluids.
Typically, people caring for a sick relative will get infected
because the fluids are very highly infectious.
Early medical care,
combined with rehydration and drugs to relieve the symptoms,
can decidedly improve one’s chances of survival.
But as yet, there is no licensed treatment
proven to neutralize the virus,
although a range of blood, immunological
and drug therapies are currently being developed.
The Ebola virus will be spread between humans
either through the blood or bodily fluids
of an infected person.
Breast milk, saliva, semen, feces
and tears are all highly infectious.
Studies have shown that traces of Ebola
may even remain in a man’s semen
for more than a year
after he has recovered from the disease.
The virus can also survive
for several days outside of the body,
so cleaning up body fluids or touching the soiled clothing
of an infected person can also lead to infection.
According to the W.H.O.,
health care workers are between 21 and 32 times more likely
to be infected with Ebola
than people in the general adult population.
They must wear a face shield,
or a medical mask and goggles,
if they are to be within one meter of a patient.
It is also necessary that workers wear
a long-sleeved gown and gloves.
Fifteen of our health workers
from this case management center have passed away.
When somebody dies of Ebola,
that time the virus is very virulent.
And in that case, we have to handle that corpse very well,
in order not for us to be infected.
Ebola infections are so deadly
because the virus infects the cells
that line your blood vessels
and this leads to massive leakage,
and essentially inner bleeding.
So it’s a very, very virulent virus
that kills you just quite rapidly.
Ebola virus is a virus
that is not constantly present in the population.
So that means there is no immunity in the population
due to having seen the virus before.
If the virus manages to be transmitted
from a patient or a victim to a new person,
then it can just very explosively expand
in the new person, and, um, be deadly.
The standard methods of treatment for Ebola patients
have remained the same for many years.
It consists of oral or intravenous rehydration
and electrolyte replacement,
coupled with drugs to decrease vomiting and diarrhea,
as well as to mitigate the symptoms of pain and fever.
Patients who are also at risk of contracting malaria
are given anti-malarial medication and antibiotics
so they don’t have to fight both diseases at once.
There are drugs being developed to treat Ebola
that stop the virus from replicating.
Another treatment being studied is the use of immunotherapy
by giving transfusions of blood from survivors.
Further potential treatment
could be the mechanical filtering of patients’ blood.
All the infections occurring in the West African Ebola epidemic
in 2014 and 2015
can be traced back to an 18-month-old boy
from the village of Meliandou, in the southern part of Guinea.
According to the American Center
for Disease Control and Prevention,
the boy is believed to have been infected by a bat.
He died on the 28th of December 2013,
followed throughout the next month by his mother,
sister and eventually, his grandmother.
On the 1st of February 2014,
a member of the deceased child’s extended family
traveled to Conakry, the capital of Guinea.
That individual died four days later,
having by then infected many other people.
The World Health Organization
opened an investigation on the 13th of March
after the Guinea Ministry of Health issued an alert
about the unidentified infections,
which they suspected was Lassa fever,
very common to the region.
Samples of the pathogen
were immediately sent to the Pasteur Institute in France.
Within a day, they confirmed that the patients
from which samples had been taken
were infected not by Lassa fever
but by Ebola.
The W.H.O. officially announced
that there was an outbreak of Ebola.
At that stage, there were already 49 confirmed cases
and 29 deaths.
It’s just amazing how this disease
can spread so widely and so silently
and then have such devastating effects in the community.
So it is very important
to not give false hope to anybody
that Ebola can be treated now.
This is absolutely not the case.
What we are relying on now
is proper implementation
of infection prevention and control,
control tracing and quarantine of people who have the disease,
quarantining of contact to make sure
that they would be under proper treatment
if they, indeed, have the disease.
Between early June and the middle of September,
the epidemic grew exponentially.
National case numbers were doubling every 16 to 30 days.
The United Nations Security Council issued a statement
stating that they were extremely concerned
about the Ebola epidemic.
They sought immediate help
from the international community
to stop any further spread of the virus.
On the 23rd of July,
the World Health Organization confirmed
that there were now more than 800 Ebola cases in the region.
The Peace Corps took the painful decision
to evacuate its volunteers from Liberia,
Sierra Leone and Guinea,
because of concerns for their health and safety.
The Center for Disease Control in America
warned U.S. residents to avoid all non-essential travel
to those countries.
By the middle of September,
there were 5000 reported cases of Ebola
and almost 2500 deaths across the globe.
At the special request of the World Health Organization,
Germany began admitting patients into the country
who required immediate treatment.
German doctors admitted a foreign patient
into a brand-new tropical medicine unit in Hamburg,
which specialized in the treatment
of contagious diseases.
Staff members of the facility assured the press
that the critically ill patient
posed no significant risk of spreading infection.
He would be treated in a special isolation ward
behind three separate air locks.
Within the isolation unit, no liquids, gases,
or particles in the air
could possibly reach the outside world.
This extraordinary safety measure was put in place,
despite how unlikely it is for Ebola
to spread through the air.
The W.H.O. said that the patient worked
in an Ebola testing laboratory in Sierra Leone.
He arrived at Hamburg airport
on the 27th of August in a specialized plane,
which had been modified to transport patients
requiring isolation.
From there, he was transferred
to a special isolation ambulance,
accompanied by a convoy of police cars on its journey
to the University Hospital Hamburg-Eppendorf.
When news of the patient’s arrival
was released to the public,
reactions were mixed.
Some expressed concern
that allowing such a contagious person into the city
could pose a genuine public health risk.
Others felt that the need to help this desperate person
far outweighed any potential for danger.
They also contended that the treatment
could aid and advance medical research.
On the 3rd of October,
Germany accepted yet another Ebola victim,
this time to a hospital in Frankfurt-am-Main.
They were flown in on a medical flight from West Africa
and transferred to the isolation unit
at Frankfurt University Hospital,
all under deep cover.
The patient was a Ugandan doctor
who had been working with Ebola patients in Sierra Leone
before falling ill with the virus himself.
Though two of his patients
responded positively to treatment,
both he and a third patient had not been so lucky.
This third patient had been a U.N. employee from Liberia
who landed in the northern German town of Leipzig,
200 kilometers southeast of Berlin,
in the early hours of the morning.
There, they were met by a medical team
wearing biohazard suits
and taken immediately to St. George hospital in Leipzig,
which had a tropical disease clinic with six rooms
where the patient could be treated
under the strictest quarantine.
Sadly, despite their best efforts,
the patient succumbed to the disease.
The first individual to die of Ebola on German soil.
On the 24th of November,
it was also confirmed
that an Italian doctor who had been working
for a medical charity treating Ebola victims in Sierra Leone
had, himself, become infected with the disease.
He was flown back to Rome
where he was successfully treated.
On the 29th of December 2014,
the United Kingdom was also drawn into the epidemic
when the first case of Ebola was confirmed in the nation.
The victim was a female nurse
who had returned from voluntary work
at an Ebola treatment center in Sierra Leone.
This case was concerning,
because her journey from Freetown
had taken her to several major global cities.
First, to Casablanca in Morocco.
Next to London, in England.
And finally, to Glasgow, in Scotland,
her ultimate destination.
After suffering from fever and headache,
she was admitted to a specialist unit
for infectious diseases
at the Gartnavel Hospital in Glasgow,
where she was kept in strict isolation.
The patient was displaying no symptoms of the kind
that would lead to onward transmission
and put other people at risk
before she had reported, this morning, as being unwell.
A day later, she was transferred
for specialist treatment at the Royal Free hospital,
where the facilities, staff and systems
were in place to ensure the safest care.
Public health authorities
began to investigate possible contacts
that the nurse may have had with other people in Britain.
It’s important to stress
that the risk to the general public remains very low,
but we are contacting the passengers
who were on the flight with her.
There’s a special dedicated help line for them to call,
so that if they have any concerns at all,
they’re able to communicate easily.
As well as liaising
with the World Health Authority in Morocco,
where the victim had changed flights
on her journey back to the U.K.
She has since made a full recovery.
As of April 2015,
there were 176 organizations in Sierra Leone,
Guinea and Liberia,
all conducting emergency programs.
Liberia was initially declared Ebola-free
by the World Health Organization
on the 9th of May 2015,
after more than 4000 people had died.
But Ebola was not yet beaten.
On the 12th of May 2015,
an Italian healthcare worker
who had been treating Ebola patients
in Sierra Leone for nearly three months,
fell ill three days after returning back to Italy.
He was taken to the infectious diseases ward
at the hospital of Sassari in Sardinia,
where he tested positive for Ebola.
Several small outbreaks reoccurred in Liberia,
with a cluster of six new cases confirmed in June 2015.
On the 3rd of September 2015,
Liberia was again declared Ebola-free
before the emergence of an additional three cases.
I came on the beach today to celebrate Ebola
because Ebola has left Liberia,
and we are going back to our normal activities.
I just came on the beach to enjoy myself because I’m alive.
Ebola did not take my life,
and none of my family alive were taken away by Ebola.
So I came on the beach today to enjoy myself.
Guinea was declared Ebola-free
on the 29th of December,
with Liberia to follow on the 14th of January 2016.
This was now its third official declaration
of complete inoculation,
only this time, things stayed that way.
People should not remain complacent.
It was the same complacence
that led to the second round of the virus emergence.
And people should continue to observe the practices
to ensure that they can remain safe.
Once Sierra Leone was given the all clear,
all three West African countries
had officially become Ebola-free.
The World Health Organization
lifted the Public Health Emergency
of International Concern related to the epidemic.
The W.H.O. reported that there had been around 28,000 cases,
with more than 11,000 deaths due to the epidemic.
But the true human cost of Ebola was much higher.
It has been estimated that over than 30,000 children
were left orphaned by the disease.
According to Médecins Sans Frontiers,
also known as Doctors Without Borders,
it is impossible to be sure how many people died
as a result of the Ebola epidemic.
In addition to those deaths
resulting directly from the Ebola virus,
there followed a dramatic increase
in latter mortality rates,
due to an increasing lack of basic health care.
This can be demonstrated by the fact that as of March 2015,
over a million fewer children were vaccinated against measles
than prior to when the epidemic began,
which undoubtedly led to more deaths from that disease.
There was also an increase in the number of people
who lacked food security
as a result of the 2014 Ebola epidemic.
This was estimated to be in the hundreds of thousands.
The health of pregnant women in West Africa
was also drastically impacted by the Ebola epidemic.
Pregnancy appeared to make women more vulnerable
to the effects of the Ebola infection.
It particularly increased their risk of hemorrhage.
There was also evidence suggesting that the virus
was able to cross from the placenta
into both the amniotic fluid and the developing fetus.
Tragically, the pregnancies of women infected with Ebola
all ended through either a spontaneous miscarriage,
stillbirth, or death of the newborn baby within a few days.
On top of the dangers Ebola presented to the mother,
healthcare workers assisting the delivery of babies
were at extreme risk of infection.
The fear of health workers treating women
from areas known to be high in Ebola cases
led to a lack of maternal care for pregnant women.
The United Nations Population Fund
estimated that the Ebola epidemic
could have either directly or indirectly
resulted in as many as 120,000 maternal deaths
by the end of October 2015.
The psychological well-being of the survivors of Ebola,
as well as the families of patients
and victims of the disease became a major concern.
I’ve met some people who have had Ebola,
and they described it in first-person terms to me.
And it’s not--
You wouldn’t wish it on your worst enemy.
In July 2014,
the first case of Ebola was diagnosed outside of Africa.
This meant that the outbreak could no longer just be viewed
as a humanitarian crisis.
It had become a palpable security threat
to countries all across the globe.
Due to the rapid interconnectedness
of the modern world,
leaders could no longer ignore
urgent health crises in distant countries,
as they would be putting their own citizens
at a greater risk of infection.
The lessons we learn,
particularly from the Ebola epidemic in 2014/15,
which affected some of the poorest countries in the world,
was that if we don’t improve
the ability of the poorest countries to respond now,
we’re going to be left, as the wealthy countries,
having to intervene later, and spending a lot more money,
a lot more people dying, a lot more risk to ourselves,
than we would if we had invested to start with,
and helped those countries develop the capacity they need.
As a result of this epidemic,
several influential figures
have called for a renewed focus
on international public health issues.
Microsoft founder Bill Gates has spent billions of dollars
working towards the eradication of global diseases.
He has advocated for building health organizations in most,
if not all, countries around the globe,
which could function
as an international early alert system
for potential new outbreaks.
Some of those same kinds of preparations
of having lists of volunteers
and knowing that people are trained and really practicing
for something very challenging,
that’s probably one of the lessons
out of this Ebola epidemic.
A flu pandemic poses the biggest challenge,
in terms of responding quickly,
because flu spreads very, very fast.
It’s about two, three days
between one person getting infected
and them infecting the next person
and the next person.
So we know how to make flu vaccines against flu pandemics.
The challenge is that we’re in a race against time
against the virus itself.
So back in 2009, it took us about five, six months,
and we were doing well,
to make large amounts of the vaccine.
And that was already too late for much of the world.
There is enormous effort now, in the intervening 10 years,
to speeding up that process.
We’re not quite there yet,
but there is the potential of new technologies
allowing us to mass produce enormous quantities of vaccine
on a much faster timescale.
And I would envisage that in the next 10 years,
those-- Those new technologies will come to fruition.
The 2014 Ebola epidemic in West Africa
highlighted major deficiencies
in the ability of the international public health
and scientific communities
to respond to infectious disease emergencies.
It also provided a stark reminder of the consequences
of not investing in the development
of healthcare infrastructure in developing countries.
The world kind of woke up to the threat of new epidemics,
really, with the SARS epidemic in 2003/4,
followed by avian influenza.
The wealthy countries in the world
then started investing significantly,
both in research, but also in preparedness.
And that is...
First of all, in health systems, better surveillance.
Picking up diseases at the earliest possible stage
in an epidemic, so you have time to do something about it.
Improving our ability to make vaccines,
for instance, against flu viruses.
Also, now, just in the last few years,
starting to actually develop vaccines
against some of these viruses,
even before they become a pandemic.
And then there’s, of course,
much of the world is not wealthy enough
to put enormous amounts of money
into epidemic preparedness.
But even there, there has been the increasing investment,
by particularly, like the U.K., Germany, the United States,
in helping countries develop healthcare infrastructure,
which enhances surveillance, more generally,
enhances their ability to respond
to that sort of emergency.
There is, however,
still an issue.
Companies are focusing
on the development of drugs and vaccines
to tackle the chronic diseases
which predominately affect people in the developed world,
and not the diseases which are more likely to cause epidemics.
If we are going to prevent future pandemics,
we must be continually developing
powerful new vaccines.
When it comes to flu, one of the things that’s interesting
and quite stunning are the recent efforts
to develop a vaccine that does not require prediction anymore.
These are called "pan-influenza" vaccines.
The idea is you find a way to vaccinate people
against any flu strain that is out there.
I think, we are relatively far away from this,
but if that worked, of course, that would be amazing.
Certainly, it’s true,
that we have an ever-present risk of a lethal pandemic.
And if we’re talking about, for instance,
a virus similar in lethality to the 1918 pandemic,
even with modern medical technologies,
that could easily cause 30 million deaths worldwide.
We must also do our best to address changes
that are occurring in the Earth’s climate,
which can affect the spread
and reach of infectious diseases.
We know from malaria, for instance,
the limits of malaria infection in the world
are dictated by the mosquitoes that can transmit it.
The limit there is that they have to survive the winter
so that the parasites can develop in the mosquitoes
and then come back next year.
Now, with global warming,
these mosquitoes can extend much more to the north
than they did in the past.
There are similar developments for viruses
that use mosquitoes to transmit.
One example is the West Nile virus in the U.S.,
which didn’t exist there,
but now is there because it can be transmitted by mosquitoes
that didn’t live there before.
So global warming
clearly plays into the distribution
of infectious diseases.
The Ebola outbreak clearly demonstrated the risk
that increasing accessibility to air travel
can pose to infection control.
As well as the spread of disease,
there is also the panic that can ensue
when infected people are moving freely and quickly
across international borders.
It is clear that within an ever more interconnected world,
the threat of diseases
spreading rapidly around the globe
has become more probable than ever.
And if a global pandemic does, indeed, become our reality,
it won’t matter who you are, or what continent you live on.
No one on this planet will be truly safe
if Mother Nature unleashes
her most inescapable deadly disaster.
Can't find what you're looking for?
Get subtitles in any language from opensubtitles.com, and translate them here.